The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Abstract
Background— The relation between endogenous testosterone concentrations and health in men is controversial. Methods and Results— We examined the prospective relationship between endogenous testosterone concentrations and mortality due to all causes, cardiovascular disease, and cancer in a nested case-control study based on 11 606 men aged 40 to 79 years surveyed in 1993 to 1997 and followed up to 2003. Among those without prevalent cancer or cardiovascular disease, 825 men who subsequently died were compared with a control group of 1489 men still alive, matched for age and date of baseline visit. Endogenous testosterone concentrations at baseline were inversely related to mortality due to all causes (825 deaths), cardiovascular disease (369 deaths), and cancer (304 deaths). Odds ratios (95% confidence intervals) for mortality for increasing quartiles of endogenous testosterone compared with the lowest quartile were 0.75 (0.55 to 1.00), 0.62 (0.45 to 0.84), and 0.59 (0.42 to 0.85), respectively ( P <0.001 for trend after adjustment for age, date of visit, body mass index, systolic blood pressure, blood cholesterol, cigarette smoking, diabetes mellitus, alcohol intake, physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuronide, and sex hormone binding globulin). An increase of 6 nmol/L serum testosterone (≈1 SD) was associated with a 0.81 (95% confidence interval 0.71 to 0.92, P <0.01) multivariable-adjusted odds ratio for mortality. Inverse relationships were also observed for deaths due to cardiovascular causes and cancer and after the exclusion of deaths that occurred in the first 2 years. Conclusions— In men, endogenous testosterone concentrations are inversely related to mortality due to cardiovascular disease and all causes. Low testosterone may be a predictive marker for those at high risk of cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, low testosterone levels in men are related to adverse events including increased cardiovascular and all-cause mortality [6–9].”
From Effects of vitamin D supplementation on androgens in men with low testosterone levels: a randomized controlled trial (2019) · cites this paper as [6]
In the citing paper
“With advancing age, testosterone levels drop, and testosterone deficiency is associated with early death, primarily from cardiovascular disease, a decrease in muscle mass and/or strength, and sexual dysfunction (46).”
From Sex-Based Differences in Skeletal Muscle Kinetics and Fiber-Type Composition (2015) · cites this paper as [46]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Huggins, C., & Hodges, C. V. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,856
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,138
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Wareham, N. J., Jakes, R. W., Rennie, K. L., Schuit, A. J., Mitchell, J., Hennings, S., & Day, N. (2003) · Public Health Nutrition · doi:10.1079/phn2002439 · Cited by 852
Self-citationDay, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Self-citationRisks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden, E. L., & Morgentaler, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022251 · Cited by 705
Androgens and Cardiovascular Disease
Liu, P. Y., Death, A. K., & Handelsman, D. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0005 · Cited by 695
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 742
Testosterone promotes vascular endothelial cell migration via upregulation of ROCK-2/moesin cascade
Liao, W., Huang, W., Guo, Y., Xin, M., & Fu, X. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2788-8 · Cited by 28
Elevated T/E2 Ratio Is Associated with an Increased Risk of Cerebrovascular Disease in Elderly Men
Gong, Y., Xiao, H., Li, C., Bai, J., Cheng, X., Jin, M., Sun, B., Lu, Y., Shao, Y., & Tian, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061598 · Cited by 28
Roles of the Androgen – Androgen Receptor System in Vascular Angiogenesis
Yoshida, S., Ikeda, Y., & Aihara, K. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31047 · Cited by 30
The concept of multiple hormonal dysregulation.
Maggio, M., Cattabiani, C., Lauretani, F., Ferrucci, L., Luci, M., Valenti, G., & Ceda, G. P. (2010) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 28
Agledahl, I., Svartberg, J. B., Hansen, J., & Brodin, E. E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0090 · Cited by 28
Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.004 · Cited by 27
Testosterone deficiency and cardiovascular mortality
Morgentaler, A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.143248 · Cited by 28
Terashima, M., Rainham, D. G. C., & Levy, A. R. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004459 · Cited by 27
Beitelshees, A. L., Johnson, J. A., Hames, M. L., Gong, Y., Cooper‐DeHoff, R. M., Wu, J., Cresci, S., Ma, C. X., Pepine, C. J., Province, M. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015180 · Cited by 27
Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?
Baas, W., & Köhler, T. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0600-8 · Cited by 27
The association between varicocoeles and vascular disease: an analysis of U.S. claims data
Wang, N. N., Dallas, K. B., Li, S., Baker, L. C., & Eisenberg, M. L. (2017) · Andrology · doi:10.1111/andr.12437 · Cited by 27
Sansone, A., Rastrelli, G., Cignarelli, A., Ponce, M. D. R., Condorelli, R. A., Giannetta, E., Maseroli, E., Pinto, S., Salzano, C., & Santi, D. (2019) · International Journal of Impotence Research · doi:10.1038/s41443-019-0163-6 · Cited by 27
Walsh, T. J., Shores, M. M., Fox, A., Moore, K. P., Forsberg, C. W., Kinsey, C. E., Heckbert, S. R., Zeliadt, S. B., Thompson, M. L., Smith, N. L., et al. (2015) · Andrology · doi:10.1111/andr.12014 · Cited by 26
An update on the role of testosterone replacement therapy in the management of hypogonadism
Hackett, G. I. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215617648 · Cited by 26
Cannarella, R., Gusmano, C., Leanza, C., Garofalo, V., Crafa, A., Barbagallo, F., Condorelli, R. A., Vignera, S. L., & Calogero, A. E. (2023) · Asian Journal of Andrology · doi:10.4103/aja202352 · Cited by 27
Serum testosterone levels correlate with haemoglobin in middle‐aged and older men
Yeap, B. B., Beilin, J., Shi, Z., Knuiman, M. W., Olynyk, J. K., Bruce, D. G., & Milward, E. A. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01789.x · Cited by 26
Park, B., Shim, J., Lee, Y., Lee, J., & Lee, H.-R. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.19 · Cited by 26
Rosen, R. C., de Araújo, A. B., Connor, M. K., Elstad, E. A., McGraw, S. A., Guay, A. T., Morgentaler, A., & Miner, M. M. (2009) · The Aging Male · doi:10.1080/13685530903184043 · Cited by 26
Malik, R. D., Wang, C. E., Lapin, B., Lakeman, J. C., & Helfand, B. T. (2015) · Urology · doi:10.1016/j.urology.2015.01.027 · Cited by 26
Testosterone Replacement Therapy: The Emperor's New Clothes
Sansone, A., Sansone, M., Lenzi, A., & Romanelli, F. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1818 · Cited by 26
Arroyo, A. B., Salloum‐Asfar, S., Pérez‐Sánchez, C., Teruel‐Montoya, R., Navarro, S., García‐Barberá, N., Luengo‐Gil, G., Roldán, V., Hansen, J., López-Pedrera, C., et al. (2017) · Scientific Reports · doi:10.1038/srep43500 · Cited by 26
Okuyama, H., Hamazaki, T., Hama, R., Ogushi, Y., Kobayashi, T., Ohara, N., & Uchino, H. (2018) · Pharmacology · doi:10.1159/000486374 · Cited by 26
Miller, C., Madden-Doyle, L., Jayasena, C. N., McIlroy, M., Sherlock, M., & O’Reilly, M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae128 · Cited by 27
Li, Y., Si, S., Hou, L., Yuan, T., Chen, X., Liu, C., Li, W., Li, H., Liu, Y., & Xue, F. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.06.037 · Cited by 25
Testosterone and coronary artery disease in men
Webb, C. M., & Collins, P. D. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.03.029 · Cited by 25
Saltiki, K., Papageorgiou, G., Voidonikola, P. T., Mantzou, A., Xiromeritis, K., Papamichael, C. M., Alevizaki, M. K., & Stamatelopoulos, K. S. (2010) · Endocrine · doi:10.1007/s12020-010-9307-7 · Cited by 25
Tsujimura, A., Yamamoto, R., Okuda, H., Yamamoto, K., Fukuhara, S., Yoshioka, I., Kiuchi, H., Takao, T., Miyagawa, Y., Nishida, M., et al. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0060 · Cited by 25
Peroxynitrite Mediates Testosterone-Induced Vasodilation of Microvascular Resistance Vessels
Puttabyatappa, Y., Stallone, J. N., Ergul, A., El‐Remessy, A. B., Kumar, S., Black, S. M., Johnson, M. H., Owen, M. P., & White, R. E. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201947 · Cited by 25
Cardiovascular effect of testosterone replacement therapy in aging male.
Francomano, D., Bruzziches, R., Natali, M., Aversa, A., & Spera, G. (2010) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 25
Hypogonadism and metabolic syndrome: review and update
Berg, W. T., & Miner, M. M. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000582 · Cited by 26
Canary in the Coal Mine? Male Infertility as a Marker of Overall Health
Punjani, N., & Lamb, D. J. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-022020-023434 · Cited by 25
Androgen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00137-4 · Cited by 26
Platz, E. A. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.104901 · Cited by 25
Lee, W. C., Kim, M. T., Ko, K., Lee, W. K., Kim, S. Y., Kim, H. Y., & Yang, D. Y. (2014) · The World Journal of Men s Health · doi:10.5534/wjmh.2014.32.3.139 · Cited by 24
Lapauw, B., & Kaufman, J. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0394 · Cited by 24
Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency
Yassin, A. A., Akhras, F., El‐Sakka, A. I., & Saad, F. (2010) · Andrologia · doi:10.1111/j.1439-0272.2009.01021.x · Cited by 24
Screening for hypogonadism in diabetes 2008/9: Results from the Cheshire Primary Care cohort
Anderson, S. G., Heald, A. H., Younger, N. O. M., Bujawansa, S., Narayanan, R. P., McCulloch, A. J., & Jones, H. T. (2011) · Primary care diabetes · doi:10.1016/j.pcd.2011.07.006 · Cited by 24
Novo, S., Iacona, R., Bonomo, V., Evola, V., Corrado, E., Piazza, M. D., Novo, G., & Pavone, C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.007 · Cited by 23
Baseline Data from the TRiUS Registry: Symptoms and Comorbidities of Testosterone Deficiency
Miner, M. M., Khera, M., Bhattacharya, R. K., Blick, G., & Kushner, H. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.05.2280 · Cited by 23
Chan, Y. X., Knuiman, M. W., Divitini, M., Handelsman, D. J., Beilby, J. P., & Yeap, B. B. (2018) · Hormones and Cancer · doi:10.1007/s12672-018-0346-5 · Cited by 23
Sex differences in preclinical models of hypertension
Olivera, S., & Graham, D. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00770-1 · Cited by 23
Scientific overview of hormone treatment used for rejuvenation
Morley, J. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.009 · Cited by 23
Elsherbiny, A., Tricomi, M., Bhatt, D., & Dandapantula, H. K. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0838-x · Cited by 23
Impact of Dihydrotestosterone on L-Type Calcium Channels in Human Ventricular Cardiomyocytes
Er, F., Gassanov, N., Brandt, M. C., Madershahian, N., & Hoppe, U. C. (2009) · Endocrine Research · doi:10.1080/07435800903136953 · Cited by 23
Rossetti, M. L., & Gordon, B. S. (2017) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2017-0230 · Cited by 22
Haring, R., Xanthakis, V., Coviello, A., Sullivan, L., Bhasin, S., Wallaschofski, H., Murabito, J. M., & Vasan, R. S. (2012) · International Journal of Andrology · doi:10.1111/j.1365-2605.2012.01285.x · Cited by 22
Zaid, M. I. A., Dinh, P. C., Monahan, P. O., Fung, C., El-Charif, O., Feldman, D. R., Hamilton, R. J., Vaughn, D. J., Beard, C. J., Cook, R., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7109 · Cited by 22
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
Bhat, S. Z., & Dobs, A. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.133 · Cited by 23
Elenkov, A., Giwercman, A., Tøttenborg, S. S., Bonde, J. P., Glazer, C. H., Hærvig, K. K., Bungum, A. B., & Nilsson, P. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237422 · Cited by 22
Cardiovascular functioning, personality, and the social world: The domain of hierarchical power
Newton, T. L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.07.005 · Cited by 22
Testosterone, SHBG and differential white blood cell count in middle-aged and older men
Brand, J. S., van der Schouw, Y. T., Dowsett, M., Folkerd, E. J., Luben, R., Wareham, N. J., & Khaw, K. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.007 · Cited by 22
Self-citationMen’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk
Miner, M. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.003 · Cited by 21
Cheung, K. K.-T., Lau, E. S. H., So, W., Ronald, C. W., Ozaki, R., Kong, A. P. S., Chow, F. C., Chan, J. C. N., & Luk, A. O. Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.012 · Cited by 21
Dubey, P., Singh, V., Venishetty, N., Trivedi, M., Reddy, S., Lakshmanaswamy, R., & Dwivedi, A. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1384603 · Cited by 21
Testosterone deficiency syndrome: Treatment and cancer risk
Raynaud, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.014 · Cited by 21
Nguyen, P. L., Jarolı́m, P., Basaria, S. S., Zuflacht, J. P., Milian, J., Kadivar, S., Graham, P. L., Hyatt, A. S., Kantoff, P. W., & Beckman, J. A. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001914 · Cited by 21
Oxidative Stress, Nutritional Antioxidants, and Testosterone Secretion in Men
Mj, G., & Smith, K. (2015) · Cited by 21
Testosterone therapy in the new era of Food and Drug Administration oversight
Desroches, B. R., Kohn, T. P., Welliver, C., & Pastuszak, A. W. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.03.13 · Cited by 21
The Cardiovascular Safety of Dutasteride
Skeldon, S., Macdonald, E. M., Law, M. R., Huang, A., Paterson, J. M., Mamdani, M., & Juurlink, D. N. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.11.082 · Cited by 21
Testosterone Replacement Therapy and Components of the Metabolic Syndrome
Anaissie, J. E., Roberts, N. H., Wang, P., & Yafi, F. A. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.01.003 · Cited by 21
Testosterone, risk, and socioeconomic position in British men: Exploring causal directionality
Hughes, A., & Meena Kumari, B. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.11.004 · Cited by 23
Lundy, S. D., Parekh, N. V., & Shoskes, D. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.03.006 · Cited by 21
Mattack, N. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11049.5381 · Cited by 21
Olsen, T. S., & Andersen, K. K. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.08.001 · Cited by 21
Fillo, J., Breza, J., Jr., Levčíkova, M., Luha, J., Vachulová, A., Durdík, Š., & Labaš, P. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0132-1 · Cited by 21
Testosterone replacement therapy and cardiovascular risk factors modification
Chahla, E. J., Hayek, M. E., & Morley, J. E. (2011) · The Aging Male · doi:10.3109/13685538.2010.541538 · Cited by 21
Khera, M., Torres, L. O., Grober, E. D., Morgentaler, A., Miner, M. M., Jones, T. H., Mills, J. N., & Salonia, A. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf036 · Cited by 21
Rago, D., Gürdeniz, G., Ravn‐Haren, G., & Dragsted, L. O. (2014) · Metabolomics · doi:10.1007/s11306-014-0668-4 · Cited by 21
Guidelines for Testosterone Therapy for Men: How to Avoid a Mad (T)ea Party by Getting Personal
Anawalt, B. D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0858 · Cited by 20
Song, C., Kim, N., Nam, R. H., Choi, S. I., Yu, J. E., Nho, H., Shin, E. H., Lee, H., & Surh, Y. (2021) · PubMed Central · Cited by 20
Sex steroids and cardiovascular disease
Yeap, B. B. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122357 · Cited by 20
Marcelli, M., & Mediwala, S. N. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001233 · Cited by 23
Foresta, C., Mambro, A. D., Caretta, N., Toni, L. D., Zuccarello, D., & Ferlin, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03507.x · Cited by 20
Applications of Dried Blood Spots in General Human Health Studies
Brindle, E., O’Connor, K. A., & Garrett, D. (2014) · Wiley eBooks · doi:10.1002/9781118890837.ch9 · Cited by 20
Shin, D. W., Han, K., Park, H. S., Lee, S., Park, S. H., & Park, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-67029-y · Cited by 19
An evolutionarily conserved olfactory receptor is required for sex differences in blood pressure
Xu, J., Choi, R., Gupta, K., Warren, H. R., Santhanam, L., & Pluznick, J. L. (2024) · Science Advances · doi:10.1126/sciadv.adk1487 · Cited by 19
Hsieh, T., Yang, Y., Lee, S., Lin, T., Liu, H.-H., Tsai, T., Chen, C., Huang, Y.-S., & Lee, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119694 · Cited by 19
Adiposity, CVD risk factors and testosterone
Gettler, L. T., Sarma, M. S., Gengo, R. G., Oka, R., & McKenna, J. J. (2017) · Evolution Medicine and Public Health · doi:10.1093/emph/eox005 · Cited by 19
Testosterone and All-Cause Mortality in Older Men: The Role of Metabolic Syndrome
Laouali, N., Brailly‐Tabard, S., Helmer, C., Ancelin, M., Tzourio, C., Singh‐Manoux, A., Dugravot, A., Elbaz, A., Guiochon‐Mantel, A., & Canonico, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00005 · Cited by 19
Yeap, B. B. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_50_17 · Cited by 19
Testosterone in renal transplant patients: effect on body composition and clinical parameters
Lofaro, D., Perri, A., Aversa, A., Aquino, B., Bonofiglio, M., Russa, A. L., Settino, M., Leone, F., Ilacqua, A., Armentano, F., et al. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0513-3 · Cited by 19
Andropause: A review of the definition and treatment
Samaras, N., Frangos, E., Forster, A., Lang, P.-O., & Samaras, D. (2012) · European Geriatric Medicine · doi:10.1016/j.eurger.2012.08.007 · Cited by 19
Moreno, Ó., & Esteva, I. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.07.004 · Cited by 20
Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
Morgentaler, A., Dhindsa, S., Dobs, A. S., Hackett, G. I., Jones, T. H., Kloner, R. A., Miner, M. M., Zitzmann, M., & Traish, A. M. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.08.008 · Cited by 18
Dogan, B. A., Karakılıç, E., Tuna, M. M., Arduç, A., Berker, D. S., & Güler, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12617 · Cited by 18
Traish, A. M. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead031 · Cited by 18
Hisasue, S. (2015) · International Journal of Urology · doi:10.1111/iju.12880 · Cited by 18
Low plasma DHEA-S increases mortality risk among male hemodialysis patients
Hsu, H.-J., Yen, C.-H., Chen, C., Hsu, K., Hsiao, C., Lee, C., Wu, I., Sun, C., Chou, C., Hsieh, M.-F., et al. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.012 · Cited by 18
Testosterone and cardiovascular disease – the controversy and the facts
Morgentaler, A., Feibus, A. H., & Baum, N. H. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.996111 · Cited by 19
Adelborg, K., Rasmussen, T. B., Nørrelund, H., Layton, J. B., Sørensen, H. T., & Christiansen, C. F. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.042 · Cited by 18
Platz, E. A., Barber, J. R., Chadid, S., Lu, J., Dobs, A. S., Kanarek, N., Nelson, W. G., Bradwin, G., McGlynn, K. A., & Rohrmann, S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00151 · Cited by 18
Testosterone Disorders and Male Hypogonadism in Kidney Disease
Garibotto, G., Esposito, P. B., Picciotto, D., & Verzola, D. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.006 · Cited by 18
Relationships between endogenous and exogenous testosterone and cardiovascular disease in men
Thirumalai, A., & Anawalt, B. D. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09752-7 · Cited by 20
Janjuha, R., Bunn, D. K., Hayhoe, R. P. G., Hooper, L., Abdelhamid, A. S., Mahmood, S., Hayden-Case, J., Appleyard, W. O., Morris, S., & Welch, A. A. (2020) · Nutrients · doi:10.3390/nu12051457 · Cited by 18
Self-citationTestosterone Deficiency, Cardiac Health, and Older Men
Hackett, G. I., Kirby, M. G., & Sinclair, A. J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/143763 · Cited by 17
Endogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women
Chehab, O., Shabani, M., Varadarajan, V., Wu, C., Watson, K. E., Yeboah, J., Post, W. S., Ambale‐Venkatesh, B., Bluemke, D. A., Michos, E. D., et al. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100320 · Cited by 17
Haring, R., Baumeister, S., Völzke, H., Kohlmann, T., Marschall, P., Fleßa, S., Nauck, M. A., & Wallaschofski, H. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.01029.x · Cited by 17
Medical Implications of Erectile Dysfunction
Berookhim, B. M., & Bar-Chama, N. C. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.08.020 · Cited by 17
Kocoglu, H., Alan, C., Soydan, H., Ateş, F., Adayener, C., Eren, A. E., Ersay, A. R., & Dayanç, M. (2011) · The Aging Male · doi:10.3109/13685538.2011.617798 · Cited by 17
Sönmez, A., Haymana, C., Aydoğdu, A., Tapan, S., Başaran, Y., Meriç, C., Başköy, K., Dinç, M., Yazıcı, M., Taşlıpınar, A., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0125 · Cited by 17
Metadata
- Authors
- Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N.
- Affiliations
- University of Cambridge (GB)
- Venue
- Circulation
- Published
- 2007-12-04
- Volume
- 116
- Issue
- 23
- Pages
- 2694-2701
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2136449685
- Cited by
- 743
- References
- 51
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 16 · 2023: 26 · 2022: 28 · 2021: 29 · 2020: 32 · 2019: 26 · 2018: 41 · 2017: 39 · 2016: 39 · 2015: 51 · 2014: 51 · 2013: 56 · 2012: 56
- FWCI
- 40.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- endogenous testosterone, all-cause mortality, cardiovascular mortality, cancer mortality, men, androgen deficiency, sex hormones, cardiovascular risk prediction, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstanediol glucuronide
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Europe, Humans, Male, Middle Aged, Neoplasms, Predictive Value of Tests, Prospective Studies, Risk Factors, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review